Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04CTO
|
|||
| Former ID |
DNC007784
|
|||
| Drug Name |
2-biphenyl-4-yl-1-phenothiazin-10-yl-ethanone
|
|||
| Synonyms |
CHEMBL240469; 2-biphenyl-4-yl-1-phenothiazin-10-yl-ethanone
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C26H19NOS
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)C2=CC=C(C=C2)CC(=O)N3C4=CC=CC=C4SC5=CC=CC=C53
|
|||
| InChI |
1S/C26H19NOS/c28-26(18-19-14-16-21(17-15-19)20-8-2-1-3-9-20)27-22-10-4-6-12-24(22)29-25-13-7-5-11-23(25)27/h1-17H,18H2
|
|||
| InChIKey |
HQYQYXMOSDNQPG-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cholinesterase (BCHE) | Target Info | Inhibitor | [1] |
| Panther Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | |||
| Muscarinic acetylcholine receptor 2 and 4 signaling pathway | ||||
| Nicotinic acetylcholine receptor signaling pathway | ||||
| WikiPathways | Irinotecan Pathway | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Selective reversible inhibition of human butyrylcholinesterase by aryl amide derivatives of phenothiazine. Bioorg Med Chem. 2007 Oct 1;15(19):6367-78. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.